StockData
Lakewood-Amedex Biotherapeutics Inc. logo

Lakewood-Amedex Biotherapeutics Inc. (LABT) stock

LABTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$0.24+0.03 (+11.89%)

Close on Nov 18, 2026Market cap $568.73KP/E –Yield –

Lakewood-Amedex Biotherapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Lakewood-Amedex Biotherapeutics's shares outstanding was 2M at Sep 30, 2026.

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 20262M+243.6%
Q2 FY2026Jun 30, 20261M-79.6%
Q1 FY2026Mar 31, 20267M–
Q3 FY2025Sep 30, 20251M–
Q2 FY2025Jun 30, 20251M–
Q1 FY2025Mar 31, 20257M–

More Lakewood-Amedex Biotherapeutics figures

See a number that looks wrong?